NCT04656821

Erector Spinae Block Versus Thoracic Paravertebral Block for Acute Thoracic Herpes Zoster

Ultrasound Guided Erector Spinae Block Versus Ultrasound Guided Thoracic Paravertebral Block for Pain Relief in Patients With Acute Thoracic Herpes Zoster

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 51 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The aim of this research is to study and compare the efficacy and safety of single injection erector spinae plane block and thoracic paravertebral block in prevention of post herpetic neuralgia in patients with acute thoracic herpes zoster.

Conditions

• Acute Thoracic Herpes Zoster
• Erector Spinae Plane Block
• Thoracic Paravertebral Block
• Pain Relief

Interventions

Type	Name	Description
DRUG	Control Rx	Patients of this group will receive standard treatment for herpes zoster which include acyclovir 800 mg, 5 times daily administered orally within the first 72 hours and analgesics as needed
PROCEDURE	Erector Spinae Block	Patients of this group will receive 25 mg bupivacaine 0.5%, plus 8 mg dexamethasone in a total volume of 10 ml (The final concentration of bupivacaine will be 0.25%) to be injected beneath the erector spinae muscle sheath) at the desired level under ultrasonography.
PROCEDURE	Thoracic Paravertebral Block	Patients of this group will receive 25 mg bupivacaine 0.5% , plus 8mg dexamethasone in a total volume of 10 ml(The final concentration of bupivacaine will be 0.25%) to be injected in the Paravertebral space at desired level under ultrasonography

Timeline

• Start date: 2020-12-05
• Primary completion: 2021-06-06
• Completion: 2021-06-20
• First posted: 2020-12-07
• Last updated: 2020-12-08

Locations

1 site across 1 country: Egypt